SPECIAL SPREAD
Clinical Product Assessment
MRT 176 Panel Safety Assessment
Clinical Narrative
The provided input identifies a product name (‘SPECIAL SPREAD’) but lacks a specific ingredient list. Clinical safety cannot be determined because specialty spreads typically contain multiple MRT-tested substances such as Soybean, Canola/Rapeseed, Cane Sugar, and Lecithin (Soy). Because the composition is unknown, this product cannot be classified as Phase 1 or 2 and requires a full ingredient declaration for analysis.
Unknown / Ambiguous Ingredients
The following ingredients could not be definitively mapped: SPECIAL SPREAD
This is procedural data interpretation, not medical guidance. Always consult your Certified LEAP Therapist.
What This Means For Your Diet
This product contains no known MRT 176 panel triggers. Based on our ingredient analysis, all components map to substances not tested on the panel, or to items that typically score Green (Low Reactive) for most patients.
However, individual MRT results vary significantly. A food that is generally safe may still be reactive for you. Always cross-reference with your personal MRT results and consult your Certified LEAP Therapist before adding any new food during Phase 1.
About This Assessment
This safety assessment was generated by cross-referencing the USDA FoodData Central ingredient record for this product against the 176 substances tested on the Mediator Release Test (MRT) panel. Clinical notes are produced with AI assistance using the matched ingredient data and reviewed by Kerry Watson, NTP, RWP for accuracy against published LEAP ImmunoCalm® protocol guidelines. Risk classifications are based on the number and type of MRT-tested substances identified. This information is for educational purposes only and is not medical advice — always consult your Certified LEAP Therapist before making dietary changes.
Find a LEAP Therapist
Get personalized guidance from a Certified LEAP Therapist in your area.
Browse Practitioners